Archives

  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • Influenza Hemagglutinin (HA) Peptide: High-Purity Epitope...

    2025-11-28

    Influenza Hemagglutinin (HA) Peptide: High-Purity Epitope Tag for Protein Purification

    Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic nine-amino acid tag derived from the human influenza virus hemagglutinin protein, designed for use in protein detection and purification workflows [APExBIO, A6004]. It exhibits high aqueous solubility (≥46.2 mg/mL in water), facilitating use in diverse experimental buffers. The peptide enables competitive binding to anti-HA antibodies, supporting efficient elution of HA-tagged fusion proteins in immunoprecipitation assays (Wei et al., 2021). APExBIO supplies it at >98% purity, confirmed by HPLC and mass spectrometry. Its functional role is essential for advanced protein-protein interaction studies and mechanistic research in exosome biology [ap24534.com].

    Biological Rationale

    The Influenza Hemagglutinin (HA) Peptide is an established epitope tag in molecular biology. Its sequence YPYDVPDYA, derived from the influenza virus hemagglutinin protein, is minimally immunogenic in most mammalian systems (Wei et al., 2021). The HA tag allows for specific recognition by monoclonal anti-HA antibodies, permitting detection, quantification, and rapid purification of HA-tagged fusion proteins. HA-tagging is widely used in protein interaction studies, exosome research, and mechanistic investigations involving multivesicular endosome (MVE) pathways [LB Broth Lennox]. The tag's small size minimizes disruption to protein folding and function, making it suitable for sensitive assays and high-throughput workflows.

    Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

    The primary utility of the HA tag peptide is in its ability to competitively bind to anti-HA antibodies. When exogenously added to immunoprecipitation reactions or affinity columns, the free peptide displaces HA-tagged proteins from anti-HA antibody complexes, enabling their controlled elution. This competitive elution preserves the integrity and activity of sensitive protein complexes, outperforming harsher methods such as low-pH or denaturing agents [ap24534.com]. The HA tag system also supports orthogonal detection via Western blot, immunofluorescence, or ELISA, as the epitope is recognized with high specificity by validated monoclonal antibodies.

    Evidence & Benchmarks

    • The HA peptide (YPYDVPDYA) enables efficient, competitive elution of HA-tagged proteins from antibody-conjugated beads under physiological buffer conditions (Wei et al., 2021, https://doi.org/10.1038/s41422-020-00409-1).
    • APExBIO's A6004 HA peptide demonstrates solubility ≥46.2 mg/mL in water, ≥55.1 mg/mL in DMSO, and ≥100.4 mg/mL in ethanol (manufacturer’s certificate, APExBIO).
    • Purity of >98% is consistently achieved, verified by HPLC and mass spectrometry (product documentation, APExBIO).
    • HA tag immunoprecipitation is compatible with detection of exosomal and endosomal fusion proteins in translational research models (Wei et al., 2021, DOI).
    • Workflow integration with anti-HA magnetic beads allows for gentle, non-denaturing recovery of protein complexes (see FUT-175.com for guidance on E3 ligase–substrate studies).

    Applications, Limits & Misconceptions

    The HA peptide is used across protein-protein interaction mapping, protein trafficking analysis, exosome biogenesis, and mechanistic studies in cancer and cell signaling. Its small size and defined sequence enable high specificity in immunoprecipitation and detection assays. The peptide’s robust solubility profile allows for use in various buffers, solvents, and experimental workflows. For a strategic perspective on maximizing translational impact, see this LB Broth Lennox article, which this review extends with updated benchmarks and mechanistic clarity.

    However, the peptide does not universally substitute for all tag systems, nor does it address all protein solubility or folding issues. Its efficacy depends on antibody specificity, tag accessibility, and the absence of interfering post-translational modifications. For a focused discussion on its mechanistic applications in protein ubiquitination, this recent article is complemented here by new quantitative solubility data and purity standards.

    Common Pitfalls or Misconceptions

    • HA peptide cannot elute non-HA-tagged proteins; it is strictly sequence-specific.
    • It does not protect against proteolysis or aggregation post-elution—additional stabilizers may be needed.
    • Long-term storage of peptide solutions is not recommended; lyophilized peptide should be stored desiccated at -20°C.
    • Competitive elution efficiency may drop if the HA tag is buried within the protein structure or blocked by post-translational modifications.
    • Cross-reactivity with non-validated anti-HA antibodies may result in nonspecific binding; only use well-characterized reagents.

    Workflow Integration & Parameters

    APExBIO’s Influenza Hemagglutinin (HA) Peptide (A6004) integrates seamlessly into established immunoprecipitation, Western blot, ELISA, and affinity purification protocols. For immunoprecipitation, recommended working concentrations range from 1–2 mg/mL for competitive elution, with adaptation depending on bead type and fusion protein abundance. The peptide’s high purity supports sensitive detection in downstream mass spectrometry or biochemical analyses. For optimal results, dissolve the lyophilized peptide in water, DMSO, or ethanol at concentrations matching assay requirements. Store the dry peptide at -20°C, desiccated, and avoid repeated freeze-thaw cycles. For advanced protocol integration, see FUT-175.com, which this review updates by providing solubility and purity benchmarks from A6004.

    Conclusion & Outlook

    The Influenza Hemagglutinin (HA) Peptide remains an indispensable tool in protein purification and molecular interaction research. Its defined sequence and high solubility enable robust, reproducible workflows for immunoprecipitation and detection of HA-tagged proteins. APExBIO’s A6004 product, with validated purity and performance, advances research in exosome biology, mechanistic cell signaling, and protein-protein interaction mapping. As protein tagging strategies evolve, the HA tag continues to provide a gold-standard, sequence-specific solution for translational and basic science laboratories. For further mechanistic applications and competitive benchmarking, see this perspective article, which this review extends by detailing storage, solubility, and purity parameters specific to A6004.